 |
 |


Antiepileptic DrugInduced Bone Loss in Young Male Patients Who Have Seizures
Dennis L. Andress, MD;
Judy Ozuna, RN, MS;
David Tirschwell, MD;
Lucinda Grande, BS;
Meshell Johnson, MD;
Arnold F. Jacobson, MD, PhD;
William Spain, MD
Arch Neurol. 2002;59:781-786.
Background Long-term antiepileptic drug (AED) therapy is a known risk factor for
bone loss and fractures. Vitamin D deficiency is frequently cited as a cause
for bone loss in patients who have seizures.
Objective To determine whether men who have seizures, but who are otherwise healthy,
suffer substantial bone loss in the hip while taking AEDs.
Patients and Methods We prospectively examined femoral neck bone mineral density (BMD) by
dual-energy x-ray absorptiometry in 81 consecutive men, aged between 25 and
54 years old (mean age, 45 years), who were attending an outpatient seizure
clinic. Low BMD values were analyzed for known risk factors for bone loss.
Dual-energy x-ray absorptiometry scans were repeated in 54 patients, 12 to
29 months later (mean, 19 months), to assess the rate of change in BMD over
time.
Results Multivariate linear regression analysis revealed that age (P<.001) and time receiving AEDs (P<.003)
were the 2 important risk factors associated with low femoral neck BMD. Neither
vitamin D deficiency, hypogonadism, cigarette smoking, nor excess alcohol
intake were associated with low BMD after correcting for age and time on AEDs.
Longitudinal analysis of femoral neck BMD revealed that only those in the
youngest age group (25-44 years) showed significant declines in femoral neck
BMD (1.8% annualized loss; 95% confidence interval, -3.1 to -0.9; P<.003) while receiving AED therapy. There was no evidence
that a specific type of AED was more causally related to bone loss in this
group although most patients were taking phenytoin sodium or carbamazepine
during the longitudinal assessment.
Conclusions Long-term AED therapy in young male patients who have seizures causes
significant bone loss at the hip in the absence of vitamin D deficiency. Dual-energy
x-ray absorptiometry scanning of the hip is useful in identifying patients
who are particularly susceptible to rapid bone loss while taking AEDs.
From the Departments of Medicine (Drs Andress and Johnson) and Neurology
(Mss Ozuna and Grande and Drs Tirschwell and Spain) and the Division of Nuclear
Medicine (Dr Jacobson), Veterans Affairs Puget Sound Health Care System and
the University of Washington School of Medicine, Seattle.
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(5):878-880.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Antiepileptic drug use and rates of hip bone loss in older men: A prospective study
Ensrud et al.
Neurology 2008;71:723-730.
ABSTRACT
| FULL TEXT
Progressive bone deficit in epilepsy
Sheth et al.
Neurology 2008;70:170-176.
ABSTRACT
| FULL TEXT
Two randomized vitamin D trials in ambulatory patients on anticonvulsants: Impact on bone
Mikati et al.
Neurology 2006;67:2005-2014.
ABSTRACT
| FULL TEXT
Advances in epilepsy
Kelso and Cock
Br Med Bull 2005;72:135-148.
ABSTRACT
| FULL TEXT
Metabolic concerns associated with antiepileptic medications
Sheth
Neurology 2004;63:S24-S29.
ABSTRACT
| FULL TEXT
Antiepileptic drug use increases rates of bone loss in older women: A prospective study
Ensrud et al.
Neurology 2004;62:2051-2057.
ABSTRACT
| FULL TEXT
More Evidence Associating AEDs with Bone Disease
JWatch Neurology 2002;2002:6-6.
FULL TEXT
|